Literature DB >> 6291953

[3H]Rauwolscine and [3H]yohimbine binding to rat cerebral and human platelet membranes: possible heterogeneity of alpha 2-adrenoceptors.

Y D Cheung, D B Barnett, S R Nahorski.   

Abstract

The specific binding of the alpha 2-adrenoceptor antagonists [3H]yohimbine and [3H]rauwolscine to membranes prepared from rat cerebral cortex and human platelets was rapid, reversible, saturable and of high affinity. Both ligands labelled an identical population of sites in cerebral or platelet membranes though the affinities of both agents were significantly lower in brain. The specific binding of [3H]yohimbine and [3H]rauwolscine in both tissues was displaced by various adrenergic agents in a manner that suggests that the labelled sites probably represent the alpha 2-adrenoceptor. There were, however, significant differences in the affinities of certain alpha-antagonists between cerebral and platelet preparations, even though these agents generated displacement curves with slopes close to unity in both tissues. Thus, whereas yohimbine, rauwolscine, WB4101 and corynanthine were all weaker in cerebral cortex, prazosin was significantly more potent at cortical than in platelet membranes. A possible heterogeneity of alpha 2-adrenoceptors is discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6291953     DOI: 10.1016/0014-2999(82)90159-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  45 in total

1.  Identification of a single alpha 1-adrenoceptor corresponding to the alpha 1A-subtype in rat submaxillary gland.

Authors:  A D Michel; D N Loury; R L Whiting
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

2.  [3H]L-654,284 as a probe of the central alpha 2 adrenoceptor.

Authors:  W C Randall; J R Huff; J P Vacca; J P Guare; R Chen; A Rosegay; J J Baldwin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-07       Impact factor: 3.000

Review 3.  Platelet alpha-adrenoceptors--a valid model for brain or vascular adrenoceptors?

Authors:  C A Hamilton; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1986-12       Impact factor: 4.335

4.  [3H] UK-14,304, a new agonist ligand of alpha 2-adrenoceptors: a comparative study with human and rat tissue.

Authors:  H Rommelspacher; S Strauss; E Fähndrich; H J Haug
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

5.  Ageing and platelet alpha 2-adrenoceptors.

Authors:  C Buckley; D Curtin; T Walsh; K O'Malley
Journal:  Br J Clin Pharmacol       Date:  1986-06       Impact factor: 4.335

6.  Differences between the alpha 2-adrenoceptor in rat submaxillary gland and the alpha 2A-and alpha 2B-adrenoceptor subtypes.

Authors:  A D Michel; D N Loury; R L Whiting
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

7.  [3H]-rauwolscine binding to alpha 2-adrenoceptors in the mammalian kidney: apparent receptor heterogeneity between species.

Authors:  C B Neylon; R J Summers
Journal:  Br J Pharmacol       Date:  1985-06       Impact factor: 8.739

8.  Pharmacological characterization of presynaptic alpha 2-autoreceptors in rat submaxillary gland and heart atrium.

Authors:  N Limberger; A U Trendelenburg; K Starke
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

9.  Presynaptic alpha 2-adrenoceptors mediating inhibition of noradrenaline and 5-hydroxytryptamine release in rat cerebral cortex: further characterization as different alpha 2-adrenoceptor subtypes.

Authors:  G Maura; G Bonanno; M Raiteri
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-04       Impact factor: 3.000

10.  Presynaptic alpha 2-autoreceptors in brain cortex: alpha 2D in the rat and alpha 2A in the rabbit.

Authors:  A U Trendelenburg; N Limberger; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-07       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.